Clinical Trial Detail

NCT ID NCT02753127
Title A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer (CanStem303C)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications

colorectal cancer

Therapies

Fluorouracil + Irinotecan + Leucovorin

Napabucasin

Age Groups: adult senior

No variant requirements are available.